IMARC Group has published a market research report titled "United States Carrier Screening Market Report by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), Medical Condition (Pulmonary Conditions, Hematological Conditions, Neurological Conditions, and Others), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others), End User (Hospitals and Clinics, Reference Laboratories, and Others), and Region 2024-2032". United States carrier screening market size is projected to exhibit a growth rate (CAGR) of 14.60% during 2024-2032.
The increasing awareness of genetic disorders and the rising demand for early detection and preventive measures are the factors responsible for the growth of the United States carrier screening market. Additionally, the need for carrier screening is growing as it offers parents the opportunity to assess their risk of passing genetic conditions on to their offspring, which is fueling the demand for services. Besides this, advancements in genetic testing technologies, such as next-generation sequencing, which allows for the comprehensive and efficient analysis of multiple genes simultaneously, are further bolstering the market. Moreover, the rising focus on personalized medicine approach and the proactive management of health risks have led more individuals to adopt carrier screening as part of their family planning process, which is contributing to the expansion of the market. The involvement of healthcare providers in recommending these tests and the integration of carrier screening into prenatal care routines are also key factors driving the market.
Grab a sample PDF of this report: https://www.imarcgroup.com/united-states-carrier-screening-market/requestsample
United States Carrier Screening Market Trends and Drivers:
The expansion of test panels to cover a broader range of genetic disorders, offering more comprehensive assessment options to individuals and couples, is the factor responsible for the growth of the United States carrier screening market. In addition to this, the population is inclined to utilize direct-to-consumer genetic testing, providing consumers with more control over their genetic health information and the convenience of at-home testing, which is creating a positive outlook for the market. Furthermore, an increase in collaboration between genetic testing companies and research institutions to improve the accuracy and predictive value of carrier screening tests is anticipated to escalate the United States carrier screening market over the forecasted period.
Report Segmentation:
The report has segmented the market into the following categories:
Type Insights:
- Expanded Carrier Screening
- Customized Panel Testing
- Predesigned Panel Testing
- Targeted Disease Carrier Screening
Medical Condition Insights:
- Pulmonary Conditions
- Hematological Conditions
- Neurological Conditions
- Others
Technology Insights:
- DNA Sequencing
- Polymerase Chain Reaction
- Microarrays
- Others
End User Insights:
- Hospitals and Clinics
- Reference Laboratories
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163